Invention Grant
- Patent Title: Treatment of filarial diseases
-
Application No.: US15542208Application Date: 2016-01-08
-
Publication No.: US10238677B2Publication Date: 2019-03-26
- Inventor: Thomas W. Von Geldern , Dale J. Kempf , Kennan C. Marsh , Mark John Taylor , Stephen Andrew Ward , Louise Ford , Joseph Turner
- Applicant: AbbVie Inc. , Liverpool School of Tropical Medicine
- Applicant Address: GB Liverpool US IL North Chicago
- Assignee: LIVERPOOL SCHOOL OF TROPICAL MEDICINE,ABBVIE INC.
- Current Assignee: LIVERPOOL SCHOOL OF TROPICAL MEDICINE,ABBVIE INC.
- Current Assignee Address: GB Liverpool US IL North Chicago
- Agency: Neal, Gerber & Eisenberg LLP
- International Application: PCT/US2016/012687 WO 20160108
- International Announcement: WO2016/112317 WO 20160714
- Main IPC: A61K31/365
- IPC: A61K31/365 ; A61K31/7048 ; C07H17/08
Abstract:
The present invention pertains to prevention of and/or treatment for filariasis. In particular, the present invention pertains to the use of tylosin A and its analogs and derivatives to prevent or treat filarial worm infection and/or diseases associated with filarial worm infection. The present invention also pertains to pharmaceutical compositions comprising tylosin A or an analog or derivative thereof for use in preventing or treating filarial worm infection and/or diseases associated with filarial worm infection.
Public/Granted literature
- US20170368088A1 TREATMENT OF FILARIAL DISEASES Public/Granted day:2017-12-28
Information query
